Email your resume to jobs@gxpsoft.ai to get matched with active biopharma roles instantly. No portals, no forms, just email.
Saram ConsultingThoughts and strategies on the intersection of Biotech, Artificial Intelligence, and Regulatory Compliance.
Microsoft open-sourced an OS-inspired governance toolkit. Google bet on identity-first Zero Trust. AWS built a deterministic policy wall outside the LLM. A deep comparison of the three platforms racing to make autonomous AI agents safe enough for production — mapped against the OWASP Agentic Top 10.
Read Article →Every QMS vendor now claims to be 'AI-powered.' A vendor-by-vendor teardown of what Veeva, MasterControl, ComplianceQuest, Dot Compliance, and nine others have actually shipped — and what it means for regulated life-sciences buyers in 2026.
Read Article →On April 2, 2026, the FDA cited a drug manufacturer for over-reliance on AI. 'The AI said so' is now a cGMP violation. A deep dive into the validation problem that every QMS vendor is avoiding: how do you validate a system that gives different answers to the same question?
Read Article →ValGenesis claims 80% faster document creation. Kneat built a four-pillar AI framework. Sware converts video into test scripts. Ketryx raised $55M to be AI-native from day one. A vendor-by-vendor teardown of who's actually automating validation — and who's just talking about it.
Read Article →Veeva shipped Falcon. Benchling shipped three products in seven days. Revvity Signals pushed its AI layer deeper. A 10-day news sweep across MES, QMS, LIMS, ELN, lab automation, and CSV/validation, and what it means for regulated software buyers.
Read Article →